Alzheimer's disease (AD) is a chronic degenerative and inflammatory process leading to synapticdysfunction and neuronal death. A review about the pharmacological treatment alternatives is made: acetylcholinesterase inhibitors (AChEI), a nutritional supplement (Souvenaid) and Ginkgo biloba. A special emphasis on Ginkgo biloba due to the controversy about its use and the approval by the European Medicines Agency is made.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S0211-139X(16)30139-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!